Advocacy
Since 1989, AIRI has been involved in monitoring federal policy and funding issues affecting biomedical research in Washington, D.C. The AIRI Washington Office has extensive experience in public policy issues related to biomedical and behavioral research and health care.
The Washington Office works closely with the AIRI Government Affairs Committee (GAC) to keep members abreast of new developments in Congress and across the federal government affecting independent research institutes; to educate policymakers about the contributions of independent research institutions to health care and economic development in this country; and to alert AIRI members to actions needed to influence their legislators in Washington. The AIRI Washington Office works to develop and maintain connections with lawmakers and various coalitions to promote common interests.
Every year, the AIRI GAC and the AIRI Washington Office establish Congressional and Executive Branch priorities. The AIRI Washington Office advocates for these priorities throughout the year through meetings with Members of Congress and staff, Executive Branch agencies, Action Alerts to the AIRI membership, and collaborative efforts with patient advocacy groups and the research and scientific communities. Below are documents illustrating some of AIRI's recent activities. For advocacy-related inquiries, please contact Nicole Parker at the AIRI Washington Office.
- AIRI FY 2025 House Written Testimony
- AIRI FY 2025 Senate Written Testimony
- AIRI Provides Feedback on Research Security Draft Policy
- AIRI Responds to NIH Public Access Plan RFI
- AIRI Responds to the HELP Committee's RFI on NIH Reauthorization
- AIRI Coalitions
- Advocacy Useful Links
